Gloria Vigueras

Gloria Vigueras

Auto-generated profile, based on publicly available information

Gloria Vigueras

Departamento de Química Inorgánica, Universidad de Murcia, Biomedical Research Institute of Murcia (IMIB-Arrixaca), E-30100 Murcia, Spain

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Coordination Chemistry Reviews
Verified
Journal Article
Closed access
AZAna Zamora
Ana Zamora
GVGloria Vigueras
Gloria Vigueras
VRVenancio Rodríguez
Venancio Rodríguez
MSM. Dolores Santana
M. Dolores Santana
JRJosé Ruiz
José Ruiz

19 March 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
VNVojtech Novohradsky
Vojtech Novohradsky
ARAnna Rovira
Anna Rovira
CHCormac Hally
Cormac Hally
AGAlex Galindo
Alex Galindo
GVGloria Vigueras
Gloria Vigueras
VMVicente Marchán
Vicente Marchán
Although cyclometalated IrIIIcomplexes have emerged as promising photosensitizers for photodynamic therapy, some key drawbacks still hamper clinical translation, such as operability in the phototherapeutic window and reactive oxygen species (ROS) production efficiency and selectivity. In this work, a cyclometalated IrIIIcomplex conjugated to a far‐red‐emitting coumarin, IrIII–COUPY, is reported with highly favourable properties for cancer phototherapy. IrIII–COUPY was efficiently taken up by HeLa cells and showed no dark cytotoxicity and impressive photocytotoxicity indexes after irradiation with green and blue light, even under hypoxia. Importantly, a clear correlation between cell death and intracellular generation of superoxide anion radicals after visible light irradiation was demonstrated. This strategy opens the door to novel fluorescent photodynamic therapy agents with promising applications in theragnosis.


6 September 2021 in Inorganic Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
GVGloria Vigueras
Gloria Vigueras
LMLenka Markova
Lenka Markova
VNVojtech Novohradsky
Vojtech Novohradsky
AMAlicia Marco
Alicia Marco
NCNatalia Cutillas
Natalia Cutillas
Viktor BrabecViktor Brabec
Viktor Brabec
Several anticancer chemotherapies, while eliminating the bulk of tumor cells, often fail, as they do not obliterate a small fraction of malignant cancer stem cells (CSCs). Thus, developing chemotherapeutics capable of targeting and abrogating CSCs, including inducing immunogenic cell death in CSCs, is essential for developing new anticancer drugs. Herein, we report octahedral Ir(III) complexes based on a benzimidazole backbone containing NH groups. The complexes exhibit low toxicity in the dark against human skin melanoma cells and high phototoxicity with blue light irradiation under both normoxic and hypoxic conditions. Additionally, complex 4 induces secretion of damage-associated molecular patterns characteristic of immunogenic cell death (ICD) in melanoma cells when the cells are irradiated with blue light. The results also suggest that the mechanism of the ICD induced by this complex may involve oxidative damage of intracellular targets by photoinduced ROS generation. This property of 4 may allow targeting the photochemotherapy based on 4 selectively to the tumor.

11 November 2016 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
JYJyoti Yellol
Jyoti Yellol
SPSergio A. Pérez
Sergio A. Pérez
GYGorakh Yellol
Gorakh Yellol
JZJuraj Zajac
Juraj Zajac
Antonio DonaireAntonio Donaire
Antonio Donaire
JRJosé Ruiz
José Ruiz
A series of 6 substitutionally inert and luminescent iridium(III) antitumor agents of the type [Ir(C∧N)2(N∧N)][PF6] containing a benzimidazole N∧N ligand with an ester group as a handle for further functionalization has been prepared. They exhibit IC50 values in the high nanomolar range in some ovarian and breast cancer cell lines (approximately 100× more cytotoxic than cisplatin (CDDP) in MDA-MB-231) and are located in the actin cortex predominantly as shown by confocal luminescence microscopy. This discovery could open the door to a new large family of drug bioconjugates with diverse and simultaneous functions.

30 July 2019 in Inorganic Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
VNVojtech Novohradsky
Vojtech Novohradsky
GVGloria Vigueras
Gloria Vigueras
JPJitka Pracharova
Jitka Pracharova
NCNatalia Cutillas
Natalia Cutillas
Christoph JaniakChristoph Janiak
Christoph Janiak
JKJana Kasparkova
Jana Kasparkova
The phototoxicity in cancer cells of three series of octahedral Ir(III) complexes of the general formula [Ir(C^N)2(N^N)][PF6], where the N^N ligand is dipyrido[3,2-a:2′,3′-c]phenazine (dppz) and the C^N ligands are deprotonated 2-phenyl-, 2-(naphthalen-2-yl)- or 2-(thiophen-2-yl)-benzimidazole derivatives (series 1, 2 and 3, respectively) with different substituents (H, methyl or 4-(trifluoromethyl)benzyl) on the imidazole units, has been studied. The 1-methyl benzimidazole compounds 2b and 3b were found to be the most photoactive in model human cervical cancer HeLa cells (IC50 about 20 nM under irradiation conditions, λexc = 420 nm), inducing a substantial formation of apoptotic bodies as shown by flow cytometry, whereas the 4-(trifluoromethyl)benzyl derivatives 1c–3c showed the highest phototoxic indexes of the three series. Notably, the antiproliferative activity of the photoactivated Ir(III) compounds was also significant under hypoxic conditions (2% O2). Fluorescence confocal microscopy investigation for 1c, 2c and 3c was undertaken, showing a significant subcellular localization of 3c in mitochondria, whereas 1c and 2c were located preferentially in the endoplasmic reticulum (ER). Further investigations on series 3 compounds using CellRox® (oxidative stress deep red reagent) have shown, after pretreatment with Tiron, that molecular superoxide radical (O2˙−) generation is mainly responsible for the oxidative stress induced by irradiation of the cells treated with the 2-(thiophen-2-yl)benzimidazole derivatives 3a–c. The photopotentiation of 3a and 3c also involves the formation of singlet oxygen (1O2), but this does not occur with 3b, due to pretreatment with sodium azide. The ROS generation was also studied by standard droethidium (DHE) and singlet oxygen sensor green (SOSG) staining assays under both normoxic and hypoxic conditions. The results showed that in tumor HeLa cells, the generation of superoxide radicals competed with singlet oxygen production in cells in normoxia, but became dominant under hypoxia.